Ascentage Pharma Group International AAPG
NASDAQ AAPG
$17.60 +0.24 (+1.38%)
As of: Sep 4, 2026 · 10:13 AM EDT

Ascentage Pharma Group International (AAPG) Prepaid Assets (2023 - 2026)

Ascentage Pharma Group International (AAPG) posted quarterly Prepaid Assets of $4.6 million for Q4 2025, down 73.2% year-over-year from $17.2 million in Q4 2024, and down 79.46% quarter-over-quarter from $22.4 million in Q2 2025.

Analysis

Ascentage Pharma Group International (AAPG) Prepaid Assets (2023 - 2026) Analysis & Trends

Ascentage Pharma Group International's Prepaid Assets history runs 3 years deep, the most recent figure standing at $4.6 million for Q4 2025.

  • In Q4 2025, Prepaid Assets fell 73.2% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $4.6 million (down 73.2% YoY), while the FY2025 annual figure was $4.7 million, down 72.38% from the prior year.
  • Prepaid Assets for Q4 2025 stood at $4.6 million, down from $22.4 million in the prior quarter.
  • The five-year high for Prepaid Assets was $22.4 million in Q2 2025, with the low at $695131.4 in Q4 2023.
  • The 3-year median for Prepaid Assets is $10.9 million (2024), against an average of $11.2 million.
  • The sharpest annual moves came in 2024 and 2025: Prepaid Assets soared 2367.58% in 2024, then slumped 73.2% in 2025.
  • Ascentage Pharma Group International's Prepaid Assets stood at $695131.4 in 2023, then jumped by 2367.58% to $17.2 million in 2024, then plunged by 73.2% to $4.6 million in 2025.
  • Business Quant data shows AAPG's Prepaid Assets at $4.6 million in Q4 2025, $22.4 million in Q2 2025, and $17.2 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
10 Ascentage Pharma Group International 1.57 Bn 1.29 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.08 Mn
Dec 31, 2025 27.15 Mn
Jun 30, 2025 22.38 Mn
Dec 31, 2024 17.15 Mn
Dec 31, 2023 12.26 Mn